CTRI/2018/01/011112已完成未知
Pazopanib in metastatic soft tissue sarcoma experience from a tertiary cancer centre in India
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Pathologically confirmed STS patient who were treated with pazopanib based therapy during the study period.
- •2.Availability of adequate clinico-pathological, treatment related details and follow-up records in EMR or case records of the patients.
排除标准
- •1.Patients who do not meet the above criteria.
- •2.Patients who has taken treatment for less than 3 months.
研究者
相似试验
已完成
2 期
Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical TrialAdvanced and / or Metastatic LiposarcomaNCT01692496Grupo Espanol de Investigacion en Sarcomas52
已完成
2 期
A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue SarcomaSarcomaNCT01593748Medical University of South Carolina90
已完成
不适用
Metastatic or Refractory Soft Tissue Sarcomas and Metronomic Cyclophosphamide: Further Assessment of Efficacy and SafetySoft Tissue SarcomaSarcomaNCT06216990Centre Hospitalier Universitaire de Besancon60
撤回
2 期
Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter TrialSoft Tissue Sarcoma AdultAdvanced CancerNCT03104335Peking University People's Hospital
已完成
不适用
A study of pazopanib in metastatic merkel cell carcinomaTopic: National Cancer Research NetworkSubtopic: MelanomaDisease: MelanomaOther malignant neoplasms of skinCancerISRCTN10125877niversity of Birmingham (UK)25